Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$107.82
-2.40-2.18%
À la fermeture: -
$107.27
-0.55-0.51%
Après les heures de négociation: 4:41 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Visteon Corp a un objectif de cours consensus de $134.32, basé sur les évaluations des 23 analystes. Le plus élevé est de $180 attribué par B of A Securities le septembre 26, 2023, et le plus bas est de $91 attribué par Guggenheim le avril 22, 2025. Les 3 dernières évaluations d'analystes ont été publiées par UBS, RBC Capital et JP Morgan le octobre 24, 2025, octobre 24, 2025 et octobre 20, 2025. Avec un objectif de cours moyen de $134 entre UBS, RBC Capital et JP Morgan, il y a une variation implicite de 24.92% upside pour Visteon Corp à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
UBS
RBC Capital
JP Morgan
Barclays
Wells Fargo
1calculé à partir des notes des analystes
Notes d'analystes pour Visteon
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/24/2025 | 32.38% | UBS | $146 → $142 | Maintains | Buy | |||
10/24/2025 | 28.65% | RBC Capital | $136 → $138 | Maintains | Outperform | |||
10/20/2025 | 13.73% | JP Morgan | $104 → $122 | Maintains | Neutral | |||
10/10/2025 | 25.85% | Barclays | $120 → $135 | Maintains | Equal-Weight | |||
09/25/2025 | 40.77% | Wells Fargo | $145 → $151 | Maintains | Overweight | |||
09/10/2025 | 30.51% | B of A Securities | $130 → $140 | Maintains | Buy | |||
09/09/2025 | 33.31% | Guggenheim | $134 → $143 | Maintains | Buy | |||
09/09/2025 | 35.17% | Wells Fargo | $129 → $145 | Maintains | Overweight | |||
08/12/2025 | -11.44% | Morgan Stanley | $90 → $95 | Maintains | Equal-Weight | |||
07/28/2025 | -3.05% | JP Morgan | $101 → $104 | Maintains | Neutral | |||
07/25/2025 | 11.87% | Barclays | $115 → $120 | Maintains | Equal-Weight | |||
07/25/2025 | 36.11% | UBS | $142 → $146 | Maintains | Buy | |||
07/25/2025 | 20.26% | Wells Fargo | $106 → $129 | Maintains | Overweight | |||
07/25/2025 | 22.12% | Deutsche Bank | $120 → $131 | Maintains | Buy | |||
07/21/2025 | -5.85% | JP Morgan | $97 → $101 | Maintains | Neutral | |||
07/16/2025 | 7.21% | Barclays | $95 → $115 | Maintains | Equal-Weight | |||
07/14/2025 | 32.38% | UBS | $85 → $142 | Upgrade | Neutral → Buy | |||
07/11/2025 | 11.87% | Goldman Sachs | $83 → $120 | Upgrade | Neutral → Buy | |||
07/11/2025 | 16.53% | Baird | $96 → $125 | Upgrade | Neutral → Outperform | |||
07/02/2025 | — | Wolfe Research | — | Upgrade | Peer Perform → Outperform | |||
07/01/2025 | -1.18% | Wells Fargo | $101 → $106 | Maintains | Overweight | |||
05/19/2025 | -16.1% | Morgan Stanley | $95 → $90 | Maintains | Equal-Weight | |||
05/19/2025 | -5.85% | Wells Fargo | $96 → $101 | Maintains | Overweight | |||
05/05/2025 | -9.57% | JP Morgan | $90 → $97 | Maintains | Neutral | |||
04/28/2025 | -10.51% | Wells Fargo | $101 → $96 | Maintains | Overweight | |||
04/25/2025 | -19.83% | Baird | $76 → $86 | Maintains | Neutral | |||
04/22/2025 | -15.17% | Guggenheim | $108 → $91 | Maintains | Buy | |||
04/15/2025 | -29.15% | Baird | $100 → $76 | Maintains | Neutral | |||
04/15/2025 | -23.56% | Barclays | $110 → $82 | Downgrade | Overweight → Equal-Weight | |||
04/10/2025 | -29.15% | UBS | $114 → $76 | Downgrade | Buy → Neutral | |||
04/10/2025 | -31.02% | Goldman Sachs | $103 → $74 | Downgrade | Buy → Neutral | |||
04/07/2025 | -5.85% | Wells Fargo | $124 → $101 | Maintains | Overweight | |||
03/03/2025 | -11.44% | Morgan Stanley | $100 → $95 | Maintains | Equal-Weight | |||
03/03/2025 | 2.54% | Barclays | $115 → $110 | Maintains | Overweight | |||
02/19/2025 | -6.78% | RBC Capital | $127 → $100 | Maintains | Outperform | |||
02/19/2025 | 15.6% | Wells Fargo | $119 → $124 | Maintains | Overweight | |||
01/24/2025 | 18.39% | RBC Capital | $124 → $127 | Maintains | Outperform | |||
01/22/2025 | 7.21% | Barclays | $140 → $115 | Maintains | Overweight | |||
12/16/2024 | 10.94% | Wells Fargo | $122 → $119 | Maintains | Overweight | |||
10/25/2024 | 15.6% | RBC Capital | $129 → $124 | Maintains | Outperform | |||
10/21/2024 | 13.73% | JP Morgan | $132 → $122 | Maintains | Neutral | |||
10/15/2024 | 30.51% | Barclays | $145 → $140 | Maintains | Overweight | |||
10/01/2024 | 9.07% | Goldman Sachs | $130 → $117 | Maintains | Buy | |||
09/20/2024 | 13.73% | Wells Fargo | $115 → $122 | Upgrade | Equal-Weight → Overweight | |||
09/10/2024 | 15.6% | Deutsche Bank | → $124 | Reinstates | → Buy | |||
09/05/2024 | — | Wolfe Research | — | Assumes | → Peer Perform | |||
08/22/2024 | 20.26% | RBC Capital | $144 → $129 | Maintains | Outperform | |||
08/14/2024 | -6.78% | Morgan Stanley | $135 → $100 | Maintains | Equal-Weight | |||
07/26/2024 | 30.51% | TD Cowen | $142 → $140 | Maintains | Buy | |||
07/26/2024 | 7.21% | Wells Fargo | $107 → $115 | Maintains | Equal-Weight | |||
07/22/2024 | 25.85% | JP Morgan | $144 → $135 | Maintains | Neutral | |||
07/12/2024 | 17.46% | Citigroup | $139 → $126 | Maintains | Buy | |||
07/12/2024 | 11.87% | Baird | $137 → $120 | Downgrade | Outperform → Neutral | |||
07/10/2024 | 23.99% | Goldman Sachs | $161 → $133 | Maintains | Buy | |||
07/10/2024 | 25.85% | UBS | $144 → $135 | Maintains | Buy | |||
06/25/2024 | -0.25% | Wells Fargo | $108 → $107 | Maintains | Equal-Weight | |||
05/10/2024 | 25.85% | Morgan Stanley | $145 → $135 | Maintains | Equal-Weight | |||
04/26/2024 | 27.72% | Baird | $140 → $137 | Maintains | Outperform | |||
04/26/2024 | 0.68% | Wells Fargo | $106 → $108 | Upgrade | Underweight → Equal-Weight | |||
04/22/2024 | 35.17% | JP Morgan | $146 → $145 | Maintains | Neutral | |||
04/17/2024 | 17.46% | Guggenheim | $136 → $126 | Maintains | Buy | |||
04/10/2024 | 35.17% | Barclays | $140 → $145 | Upgrade | Equal-Weight → Overweight | |||
03/07/2024 | 36.11% | RBC Capital | $188 → $146 | Maintains | Outperform | |||
02/29/2024 | 49.16% | B of A Securities | $165 → $160 | Maintains | Buy | |||
02/21/2024 | -1.18% | Wells Fargo | $101 → $106 | Maintains | Underweight | |||
01/25/2024 | 37.97% | JP Morgan | $160 → $148 | Maintains | Neutral | |||
01/24/2024 | 30.51% | Barclays | $158 → $140 | Maintains | Equal-Weight | |||
01/17/2024 | 35.17% | UBS | $143 → $145 | Upgrade | Neutral → Buy | |||
01/11/2024 | 74.33% | RBC Capital | $187 → $187 | Reiterates | Outperform → Outperform | |||
01/04/2024 | — | Wolfe Research | — | Downgrade | Outperform → Peer Perform | |||
12/13/2023 | 21.19% | Exane BNP Paribas | → $130 | Downgrade | Outperform → Neutral | |||
11/06/2023 | 38.9% | Citigroup | → $149 | Upgrade | Neutral → Buy | |||
10/27/2023 | 33.31% | UBS | $146 → $143 | Maintains | Neutral | |||
10/12/2023 | — | Barclays | — | Upgrade | Underweight → Equal-Weight | |||
10/11/2023 | 38.9% | Citigroup | $160 → $149 | Maintains | Neutral | |||
10/10/2023 | 36.11% | UBS | $157 → $146 | Maintains | Neutral | |||
10/03/2023 | 14.66% | Wells Fargo | $138 → $123 | Maintains | Underweight | |||
09/26/2023 | 67.8% | B of A Securities | → $180 | Reinstates | → Buy | |||
09/13/2023 | 46.36% | UBS | → $157 | Initiates | → Neutral | |||
08/07/2023 | 25.85% | Barclays | $130 → $135 | Maintains | Underweight | |||
08/04/2023 | 69.67% | RBC Capital | $184 → $182 | Maintains | Outperform | |||
08/04/2023 | 28.65% | Wells Fargo | $130 → $138 | Maintains | Underweight | |||
07/20/2023 | 46.36% | JP Morgan | $156 → $157 | Maintains | Neutral | |||
07/18/2023 | 49.16% | Citigroup | $159 → $160 | Maintains | Neutral | |||
07/10/2023 | 21.19% | Wells Fargo | $127 → $130 | Maintains | Underweight | |||
06/08/2023 | 63.14% | Wolfe Research | → $175 | Upgrade | Peer Perform → Outperform | |||
05/17/2023 | 50.09% | Guggenheim | → $161 | Upgrade | Neutral → Buy | |||
05/01/2023 | 48.22% | Citigroup | $165 → $159 | Maintains | Neutral | |||
04/28/2023 | 18.39% | Wells Fargo | $126 → $127 | Maintains | Underweight | |||
04/17/2023 | 21.19% | Barclays | $135 → $130 | Maintains | Underweight | |||
04/10/2023 | 17.46% | Wells Fargo | $125 → $126 | Maintains | Underweight | |||
03/14/2023 | 53.82% | Citigroup | $145 → $165 | Maintains | Neutral | |||
03/09/2023 | 35.17% | Morgan Stanley | $135 → $145 | Maintains | Equal-Weight | |||
03/08/2023 | 71.53% | RBC Capital | $169 → $184 | Maintains | Outperform | |||
02/21/2023 | 25.85% | Morgan Stanley | $115 → $135 | Maintains | Equal-Weight | |||
02/17/2023 | 16.53% | Wells Fargo | $102 → $125 | Maintains | Underweight | |||
02/17/2023 | 67.8% | Goldman Sachs | $160 → $180 | Maintains | Buy | |||
02/17/2023 | 58.48% | Baird | $163 → $170 | Maintains | Outperform | |||
02/17/2023 | — | Guggenheim | — | Downgrade | Buy → Neutral | |||
02/15/2023 | 16.53% | Barclays | → $125 | Initiates | → Underweight |
FAQ
Quel est le cours indicatif de l'action Visteon (VC) ?
Le dernier objectif de prix pour Visteon (NASDAQ:VC) a été rapporté par UBS le octobre 24, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $142.00 s'attendant à ce que VC se rise dans les 12 prochains mois (un possible changement de 32.38% upside). 40 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Visteon (VC) ?
La dernière note d'analyste pour Visteon (NASDAQ:VC) a été fournie par UBS, et Visteon maintenu leur note buy.
Quand a eu lieu la dernière mise à niveau pour Visteon (VC) ?
La dernière amélioration pour Visteon Corp a eu lieu le juillet 14, 2025 lorsque UBS a augmenté leur objectif de prix à $142. UBS avait précédemment a neutral pour Visteon Corp.
Quand a eu lieu la dernière dégradation pour Visteon (VC) ?
La dernière réduction pour Visteon Corp a eu lieu le avril 15, 2025 lorsque Barclays a changé leur objectif de prix de $110 à $82 pour Visteon Corp.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Visteon (VC) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Visteon, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Visteon a été déposée le octobre 24, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 24, 2026.
La note d'analyste pour Visteon (VC) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Visteon (VC) était un maintenu avec un objectif de prix de $146.00 à $142.00. Le prix actuel de Visteon (VC) est de $107.27, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.